PR Newswire
PLYMOUTH MEETING, Pa.
, March 12, 2025 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious diseases, today announced that fourth quarter and year-end 2024 financial results will be released after the market close on March 18, 2025. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.
The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancers, and infectious diseases. INOVIO’s technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Contacts
Media: Jennie Willson, (267) 429-8567, [email protected]
Investors: Peter Vozzo – ICR Healthcare, (443) 213-0505, [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-fourth-quarter-and-year-end-2024-financial-results-on-march-18-2025-302400150.html
SOURCE INOVIO Pharmaceuticals, Inc.
